Managed Healthcare Executive October 23, 2023
The diabetes management space is heading toward a shift as 1.5 million new Medicare beneficiaries are projected to soon gain eligibility for Continuous Glucose Monitors (CGMs).
The expansion, while promising for improved diabetes management, poses challenges for health plans in terms of costs, resource management and the need for effective strategies to navigate the influx of first-time CGM users.
Arti Masturzo, MD, CMO of CCS, told Managed Healthcare Executive, before the local coverage determination (LCD) change, domestic spending on CGMs was approximately 8 billion. However, with the “widened pool” of individuals gaining access to CGMs, this figure is expected to double over the next 24 months.
The impact on Medicare Advantage plans, in particular, is expected to be significant with...
Today's Sponsors
Today's Sponsor